These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 18790549)
101. Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease. Filali M; Lalonde R; Rivest S Physiol Behav; 2011 Oct; 104(5):880-5. PubMed ID: 21640739 [TBL] [Abstract][Full Text] [Related]
103. Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Rutten BP; Van der Kolk NM; Schafer S; van Zandvoort MA; Bayer TA; Steinbusch HW; Schmitz C Am J Pathol; 2005 Jul; 167(1):161-73. PubMed ID: 15972962 [TBL] [Abstract][Full Text] [Related]
104. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768 [TBL] [Abstract][Full Text] [Related]
111. Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice. Roder S; Danober L; Pozza MF; Lingenhoehl K; Wiederhold KH; Olpe HR Neuroscience; 2003; 120(3):705-20. PubMed ID: 12895511 [TBL] [Abstract][Full Text] [Related]
112. Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease. Arrieta-Cruz I; Wang J; Pavlides C; Pasinetti GM J Alzheimers Dis; 2010; 21(2):649-54. PubMed ID: 20571219 [TBL] [Abstract][Full Text] [Related]
113. Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer's Disease Model. Shen Y; Tian M; Zheng Y; Gong F; Fu AKY; Ip NY Cell Rep; 2016 Nov; 17(7):1819-1831. PubMed ID: 27829153 [TBL] [Abstract][Full Text] [Related]
114. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173 [TBL] [Abstract][Full Text] [Related]
115. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Liu L; Orozco IJ; Planel E; Wen Y; Bretteville A; Krishnamurthy P; Wang L; Herman M; Figueroa H; Yu WH; Arancio O; Duff K Neurobiol Dis; 2008 Jul; 31(1):46-57. PubMed ID: 18504134 [TBL] [Abstract][Full Text] [Related]
116. Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice. Li PP; Wang WP; Liu ZH; Xu SF; Lu WW; Wang L; Wang XL Acta Pharmacol Sin; 2014 Jul; 35(7):869-78. PubMed ID: 24858312 [TBL] [Abstract][Full Text] [Related]
117. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease. Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046 [TBL] [Abstract][Full Text] [Related]
118. Reductions in endocannabinoid levels and enhanced coupling of cannabinoid receptors in the striatum are accompanied by cognitive impairments in the AβPPswe/PS1ΔE9 mouse model of Alzheimer's disease. Maroof N; Ravipati S; Pardon MC; Barrett DA; Kendall DA J Alzheimers Dis; 2014; 42(1):227-45. PubMed ID: 24844690 [TBL] [Abstract][Full Text] [Related]
119. Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease. Seo HJ; Park JE; Choi SM; Kim T; Cho SH; Lee KH; Song WK; Song J; Jeong HS; Kim DH; Kim BC Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445678 [TBL] [Abstract][Full Text] [Related]
120. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases. Zare D; Rajizadeh MA; Maneshian M; Jonaidi H; Sheibani V; Asadi-Shekaari M; Yousefi M; Esmaeilpour K Psychopharmacology (Berl); 2021 Jun; 238(6):1645-1656. PubMed ID: 33624157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]